Understanding the precise mechanisms by which Bcl-2 family proteins drive cancer progression, drug resistance, and sustained cell survival is crucial for identifying effective therapeutic targets aimed at restoring apoptotic balance in tumor cells. The gene discussed is BCL2; the disease is neoplasm.